HBI Deals+Insights / M&A/IPOs

Ober Scharrer “priced aggressively” as sale expected by May

We've been keeping our eye on German ophthalmology chain Ober Scharrer for months, and at long last we hear a sale looks imminent. Healthcare Europa speaks to a source in Germany about who is still in the running, and whether the prospective price could be putting buyers off.

We would welcome your thoughts on this story. Email your views to David Farbrother or call 0207 183 3779.